Register Now: Our Mega Summit Goes LIVE at 5pm Today
Here is the latest dividend payout history of HIKAL CHEMIC. For more details, see the HIKAL CHEMIC financial fact sheet and HIKAL CHEMIC share price and chart. For a sector overview, read our pharmaceuticals sector report.
Year End | Mar-17 | Mar-18 | Mar-19 | Mar-20 | Mar-21 | |
---|---|---|---|---|---|---|
Face value | Rs | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Dividend | % | 60.00 | 60.00 | 60.00 | 60.00 | 100.00 |
Dividend per share (Unadj.) | Rs | 1.20 | 1.20 | 1.20 | 1.20 | 2.00 |
Dividend per share (Adj.) | Rs | 0.80 | 0.80 | 1.20 | 1.20 | 2.00 |
Dividend payout ratio | % | 14.6 | 12.8 | 14.4 | 17.5 | 18.5 |
Dividend yield (eoy) | % | 0.6 | 0.6 | 0.7 | 1.7 | 1.4 |
More Pharmaceuticals Company Dividend Payout: CIPLA DR. REDDYS LAB SUN PHARMA LUPIN PIRAMAL ENTERPRISES
Compare HIKAL. With: CIPLA DR. REDDYS LAB SUN PHARMA LUPIN PIRAMAL ENTERPRISES
Indian share markets traded in a rangebound fashion throughout the day today to end flat.
It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.
Here's why Divi's Lab's stock fell over 10% in two days.
For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.
During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.
The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?
More Views on NewsWith India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.
Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.
Some sectors have corrected by 50%. Do they merit a look?
This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.
Prudent investors should consider dividend aristocrats to create passive, predictable, and growing income to rely on whether the market moves up or down in these uncertain times.
More